Título: | DEVELOPMENT OF A PHOTOCHEMICAL DERIVATIZATION PROCEDURE FOR TWO SYNTHETIC GLUCOCORTICOIDS (PREDNISOLONE AND TRIAMCINOLONE ACETONIDE) AIMING THE SPECTROFLUORIMETRIC ANALYSIS OF PHARMACEUTICAL FORMULATIONS | |||||||
Autor: |
ANETE LOPES COELHO |
|||||||
Colaborador(es): |
RICARDO QUEIROZ AUCELIO - Orientador |
|||||||
Catalogação: | 08/ABR/2005 | Língua(s): | PORTUGUESE - BRAZIL |
|||||
Tipo: | TEXT | Subtipo: | THESIS | |||||
Notas: |
[pt] Todos os dados constantes dos documentos são de inteira responsabilidade de seus autores. Os dados utilizados nas descrições dos documentos estão em conformidade com os sistemas da administração da PUC-Rio. [en] All data contained in the documents are the sole responsibility of the authors. The data used in the descriptions of the documents are in conformity with the systems of the administration of PUC-Rio. |
|||||||
Referência(s): |
[pt] https://www.maxwell.vrac.puc-rio.br/projetosEspeciais/ETDs/consultas/conteudo.php?strSecao=resultado&nrSeq=6260&idi=1 [en] https://www.maxwell.vrac.puc-rio.br/projetosEspeciais/ETDs/consultas/conteudo.php?strSecao=resultado&nrSeq=6260&idi=2 |
|||||||
DOI: | https://doi.org/10.17771/PUCRio.acad.6260 | |||||||
Resumo: | ||||||||
The synthetic glucocorticoid such as triamcinolone
acetonide and
prednisolone neither present natural fluorescence nor
fluorescence can be induced
by means of the standard procedure used for natural
glucocorticoids which
consists on a treatment with concentrated sulfuric acid. In
the present work, a
photochemical derivatization procedure for these two
synthetic glucocorticoids
was developed and carefully optimized aiming the obtantion
of fluorescent
derivatives stable enough to allow the development of a
spectrofluorimetric
method for determination of these analytes in
pharmaceutical formulations. The
photochemical derivatization procedure consisted on the
exposure of acidic
solutions of these synthetic glucocorticoids to the
ultraviolet radiation (300 nm) in
a photochemical reactor. Experimental parameters such as
type and concentration
of the acid, temperature and heating time, solvent system
and UV exposition time
have shown to be critical and therefore they were carefully
studied. The design of
the photochemical reactor) has also shown to be relevant
for the success of the
procedure. The intensity of the fluorescence (with maximum
excitation and
emission wavelenghts at 240 nm and 350 nm respectively) and
the stability of
these photoproducts, have shown to be appropriated for the
development of a
spectrofluorimetric method. Important instrumental
parameters such as spectral
bandpass and scan velocity have been optimized aiming the
achievement of best
signal-to-blank ratio and spectral resolution. Analytical
parameters of merit,
obtained from the analytical curve, have indicated limits
of detention of 5 and 6
ng mL-1 for triamcinolone acetonide and prednisolone,
respectively, and limits of
quantification of 17 ng mL-1 for triamcinolone acetonide
and 18 ng mL-1 for
prednisolone. The linear dynamic range for both analytes
extended over three
orders of magnitude with linear coefficients (r2) of 0,99.
The spectrofluorimetric
method was tested by the analysis of pharmaceutical
formulations, with best performance for tablets and
injectable solutions. A study to evaluate the effect of
two potential interferents (polimixine B and benzocaine)
has also been made.
Recovery results were evaluated using both, the reference
values indicated in the
medicine instructions and concentration values obtained
using the reference
procedure (HPLC with UV-visible photometric detection) used
in the Brazilian
Jockey Club. Satisfactory recovery results were achieved
(between 97 ± 14 and
104 ± 6 %).
|
||||||||